Myrbetriq (mirabegron) relaxes the muscles of the urinary bladder, reducing bladder spasms. It is used alone or with solifenacin succinate to treat the symptoms of overactive bladder, such as frequent or urgent urination and urinary incontinence.
Myrbetriq is used in adults to treat overactive bladder with symptoms of frequent or urgent urination and urinary incontinence. It is sometimes used together with another medicine called solifenacin (Vesicare).
Myrbetriq is used in children to treat neurogenic detrusor overactivity (NDO). Urinary incontinence caused by NDO is related to permanent nerve damage from conditions such as multiple sclerosis or spinal injury.
Myrbetriq tablets may be used in children at least 3 years old. Myrbetriq granules are for use in children at least 3 years old who also weigh at least 77 pounds (35 kilograms).
